Diffuse Lewy body disease: Clinical features in nine cases without coexistent Alzheimer's disease

Journal of Neurology Neurosurgery and Psychiatry

Volumn 60, Issue 5, 1996, Pages 531-538

  Hely, M A ^a   Reid, W G J ^a   Halliday, G M ^b   McRitchie, D A ^b   Leicester, J ^c   Joffe, R ^d   Brooks, W ^e   Broe, G A ^e   Morris, J G L ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^d ROYAL NORTH SHORE HOSPITAL   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Dementia; Diffuse Lewy body disease; Parkinson's disease

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DEMENTIA; DIFFUSE LEWY BODY DISEASE; FEMALE; HALLUCINATION; HUMAN; LEWY BODY; MALE; MESENCEPHALON; PARKINSONISM; PATHOLOGY; PRIORITY JOURNAL; TREMOR;

EID: 0029993589     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.60.5.531     Document Type: Article

References (47)

1. Lippa CF, Smith TW, Swearer JM. Alzheimer's disease and Lewy body disease: a comparative clinico-pathological study. Ann Neurol 1994;35:81-8.
2. Kosaka K. Dementia and neuropathology in Lewy body disease. Adv Neurol 1993;60:456-63.
3. Gibb WRG, Luthert PJ, Janota I, Lantos PL. Cortical Lewy body dementia: clinical features and classification. J Neurol Neurosurg Psychiatry 1989;52:185-92.
4. Perry RH, Irving D, Blessed G, Fairbairn A, Kerry EK. Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 1990;95:119-39.
5. Ince P, Irving D, MacArther F, Perry RH. Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non demented elderly control patients. J Neurol Sci 1991;106:142-52.
6. Forno LS, Barbour PJ, Norville RI. Presenile dementia with Lewy bodies and neurofibrillary tangles. Arch Neurol 1978;35:818-22.
7. Gibb WG, Esiri MM, Lees AJ. Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain 1985;110:1131-53.
8. Hansen LA, Salmon D, Galasko D, et al. The Lewy body variant of Alzheimer's disease: a clinical and pathological entity. Neurology 1990;40:1-8.
9. Gibb WRG, Mountjoy CQ, Mann DMA, Lees AJ. A pathological study between Lewy body disease and Alzheimer's disease. J Neurol Neurosurg Psychiatry 1989; 52:701-8.
10. Rosenblum WI, Ghatak NR. Lewy bodies in the presence of Alzheimer's disease. Arch Neurol 1979;36:170-1.
11. Boller E, Mizutani T, Roessmann U, Gambetti P. Parkinson's disease, dementia and Alzheimer's disease. Ann Neurol 1980;7:329-35.
12. Vermersch P. Dementia in Parkinson's disease. Ann Neurol 1993;33:445-50.
13. Hughes AJ, Daniel SE, Blankson S, Lees AJ. A clinico-pathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993;50:140-8.
14. Kuzuhara S, Yoshimura M. Clinical and neuropathological aspects of diffuse Lewy body disease in the elderly. Adv Neurol 1993;60:464-9.
15. McKeith IG, Perry RH, Fairbairn AF, Jabeen S, Perry EK. Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 1992;22:911-22.
16. Byrne EJ, Lennox G, Lowe J, Godwin-Austen RB. Diffuse Lewy body disease: clinical features in 15 cases. J Neurol Neurosurg Psychiatry 1989;52:709-17.
17. Mark MH, Sage JI, Dickson DW, Schwarz KO, Duvoisin RC. Levodopa-nonresponsive Lewy body parkinsonism: clinico-pathologic study of 2 cases. Neurology 1992;42: 1323-7.
18. Louis ED, Goldman JE, Powers JM, Fahn S. Parkinsonian features of eight pathologically diagnosed cases of diffuse Lewy body disease. Mov Disord 1995;10:188-94.
19. Lennox G, Lowe J, Morrell K, Landon M, Mayer RJ. Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease. J Neurol Neurosurg Psychiatry 1989;52: 67-71.
20. Dickson DW, Ruan D, Crystal H, et al. Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD. Neurology 1991;41:1402-9.
21. Halliday GM, Flowers D, Baum L. Analysis of staining methods for different cortical plaques in Alzheimer's disease. Acta Neuropathol (Berl) 1994;87:174-86.
22. Love S, Nicholl JAR. Comparison of modified Bielschowsky silver impregnation and anti-ubiquitin immunostaining of cortical and nigral Lewy bodies. Neuropathol Appl Neurobiol 1992;18:585-92.
23. Pamphlett R, Morris J, Leicester J. A woman with dementia and Parkinsonism unresponsive to levodopa. Med J Aust 1988;149:490-4.
24. Hansen LA, Masliah E, Galasko D, Terry RD. Plaque-only Alzheimer disease is usually the Lewy body variant, and vice versa. J Neuropathol Exp Neurol 1993;52:648-54.
25. Mirra S, Heyman A, McKeel D, et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardisation of the neuropathological assessment of Alzheimer's disease. Neurology 1991;41:479-86.
26. Okazaki H, Lipkin LE, Aronson SM. Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion. J Neuropathol Exp Neurol 1961;20:237-44.
27. Yoshimura M. Pathological basis for dementia in elderly patients with idiopathic Parkinson's disease. Eur Neurol 1988;28(suppl 1):29-35.
28. Sugiyama H, Hainfellner JA, Yoshimura M, Budka H. Neocortical changes in Parkinson's disease revisited. Clin Neuropathol 1994;13:55-9.
29. Eggertson DE, Sima AAF. Dementia with cerebral Lewy bodies. Arch Neurol 1986;43:524-7.
30. Cummings JL, Benson DF. Dementia. A clinical approach. 2nd ed. Oxford: Butterworth-Heinemann 1992:9-10.
31. Förstl H, Burns A, Luthert P, Cairns N, Levy R. A Lewy body variant of Alzheimer's disease. Clinical and pathological findings. Br J Psychol 1993;162:385-92.
32. McKeith I, Fairbairn A, Perry R, Thompson P, Perry E. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ 1992;305:673-8.
33. McKeith IG, Fairbairn AF, Perry RH, Thompson P. The clinical diagnosis and misdiagnosis of senile dementia of Lewy body type (SDLT). Br J Psychol 1994;165:324-32.
34. Hely MA, Morris JGL, Reid WGJ, et al. Age of onset: the major determinate of outcome in Parkinson's disease. Acta Neurol Scand 1995;92:455-65.
35. Stern Y, Mayeux R, Sano M, Hauser WA, Bush T. Predictors of disease cause in patients with probable Alzheimer's disease. Neurology 1987;37:1649-53.
36. Crowe SF, Peppard RF, Borenstein R, Lloyd JH. Diffuse Lewy body disease and progressive dementia in a young woman. ANZ J Psych 1992;26:507-11.
37. Starkstein SE, Preziosi TJ, Bolduc PC, Pobinson RG. Depression in Parkinson's disease. J Nerv Ment Dis 1990;178:27-31.
38. Burkhardt CR, Filley CM, Kleinschmidt-DeMasters BK, et al. Diffuse Lewy body disease and dementia. Neurology 1988;38:1520-8.
39. Jankovic J, Rhajput AH, Golbe LJ, Goodman JC. What is it? Case I, 1993: parkinsonism, dysautonomia and ophthalmoparesis. Mov Disord 1993;8:525-32.
40. Wenning GK, Ben Shlomo Y, Magalhães M, Daniel SE, Quinn NP. Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain 1994;117:835-45.
41. Crystal HA, Dickson CW, Lizardi JE, Davies P, Wolfson LI. Antimortum diagnosis of diffuse Lewy body disease. Neurology 1990;40:1523-8.
42. Hedera P, Cohen ML, Lerner AJ, Friedland RP. Dementia preceeding motor symptoms in Parkinson's disease. A case study. Neuropsychiatry, Neuropsychology and Behavioural Neurology 1994;7:67-72.
43. Hely MA, Morris JGL, Reid WGJ, et al. The Sydney multi centre study of Parkinson's disease: a randomised prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa. J Neurol Neurosurg Psychiatry 1994;57:903-10.
44. Khachaturian ZV. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-104.
45. McKeith IG, Fairbairn AF, Bothwell RA, et al. An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology 1994;44:872-7.
46. Armstrong RA. Beta-amyloid deposition in the medial temporal lobe in elderly non-demented brains and in Alzheimer's disease. Dementia 1995;6:121-5.
47. Braak H and Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82: 239-59.